##plugins.themes.academic_pro.article.main##
Abstract
Rheumatoid arthritis (RA) is a chronic, recurrent inflammatory autoimmune condition characterized by persistent inflammation of the synovial joints, which over time and especially without intensive treatment, leads to erosive development, with the destruction of the articular cartilage and complete loss of joint integrity
Keywords
Rheumatoid arthritis
Juvenile idiopathic arthritis
Psoriatic arthritis
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Dr. Ruaa Abdulelah Mohammed Oleiwi, Dr. Nibras Shaheed Noori, & Dr. Rasha Abdul-Ridha Musa. (2023). The impact of rheumatic diseases in Iraq on pregnant women whose ages range from (25-35 years). Texas Journal of Medical Science, 17, 51–58. https://doi.org/10.62480/tjms.2023.vol17.pp51-58
References
- Katz PP. Childbearing decisions and family size among women with rheumatoid arthritis. Arthritis Rheum. 2006;55:217–23. [PubMed] [Google Scholar]
- Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2539–49. [PubMed] [Google Scholar]
- Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550–8. [PubMed] [Google Scholar]
- Chambers CD, Johnson DL, Jones KL. Pregnancy outcome in women exposed to anti-TNFalpha medications. The OTIS Rheumatoid Arthritis in Pregnancy Study. Arthritis Rheum. 2004;50:S479. [Google Scholar]
- Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–32. [PMC free article] [PubMed] [Google Scholar]
- Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M. Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:984–90. [PubMed] [Google Scholar]
- Forger F, Villiger PM, Ostensen M. Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role? Arthritis Rheum. 2009;61:279–83. [PubMed] [Google Scholar]
- Romero-Diaz J, Garcia-Sosa I, Sanchez-Guerrero J. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. J Rheumatol. 2009;36:68–75. [PubMed] [Google Scholar]
- Salmon JE, Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol. 2008;77:51–6. [PMC free article] [PubMed] [Google Scholar]
- Watkins DA, Johnson CO, Colquhoun SM, et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015. N Engl J Med. 2017;377(8):713–722. pmid:28834488.
- Zühlke LJ, Steer AC. Estimates of the Global Burden of Rheumatic Heart Disease. Glob Heart. 2013;8 (3):189–195. pmid:25690495.
- Sanghavi M, Rutherford JD. Cardiovascular Physiology of Pregnancy. Circulation. 2014;130 (12):1003–1008. pmid:25223771.
- Baghel J, Keepanasseril A, Pillai AA, Mondal N, Jeganathan Y, Kundra P. Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease. Heart. 2020. pmid:32601124.
- Perelshtein Brezinov O, Simchen MJ, Ben Zekry S, Kuperstein R. Maternal and Neonatal Complications of Pregnant Women with Mitral Stenosis. Isr Med Assoc J. 2019;21 (2):88–93. pmid:30772958.
- van Hagen IM, Thorne SA, Taha N, et al. Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease. Circulation.137 (8):806–816. pmid:29459466.
- Tsiaras S, Poppas A. Mitral valve disease in pregnancy: outcomes and management. Obstet Med. 2009;2 (1):6–10. pmid:27582798.
- Hartkopf J, Schleger F, Keune J, et al. Impact of Intrauterine Growth Restriction on Cognitive and Motor Development at 2 Years of Age. Front Physiol. 2018;9:1278–1278. pmid:30283344.
- Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice. J Am Soc Ecocardiogr. 2009;22 (1):1–23. pmid:19130998.
- Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLOS Medicine. 2009;6 (7):e1000097. pmid:19621072.
- iaw J, Gorton S, White A, Heal C. Pregnancy outcomes in patients with rheumatic mitral valve disease: A systematic review and meta-analysis: National Institute for health research. PROSPERO. 2020; CRD42020161529.
- Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. pmid:28935701.
- Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing Bias in Studies of Prognostic Factors. Ann Intern Med. 2013;158 (4):280–286. pmid:23420236.
- Higgins JPT, et al. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester (UK): John Wiley & Sons; 2019.
- Metelli S, Chaimani A. Challenges in meta-analyses with observational studies. Evid Base Ment Health. 2020;23 (2):83. pmid:32139442.
- Pregnancy Outcomes in Women With Rare Autoimmune Diseases. Chen JS, Roberts CL, Simpson JM, March LM Arthritis Rheumatol, (12):3314-3323 2015 MED: 26434922
- Ostensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Forger F, Wahren-Herlenius M, Ruiz-Irastorza G, Koksvik H, Nelson-Piercy C, Shoenfeld Y, Tincani A, Villiger PM, Wallenius M, von Wolff M Autoimmun Rev, (5):376-386 2014
- Peart E, Clowse ME Curr Opin Rheumatol, (2):118-123 2014 MED: 24419751
- Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA J Thromb Haemost, (2):295-306 2006.